Cubist Systematic Strategies, LLC Co Diagnostics, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $12,227 - $20,455	-3,252 Reduced 5.54%	55,471 $311,000
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $317,448 - $606,496	-63,111 Reduced 51.8%	58,723 $363,000
Q4 2021 Feb 14, 2022	BUY	$8.12 - $10.37 $371,928 - $474,987	45,804 Added 60.24%	121,834 $1.09 Million
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $87,628 - $133,316	-11,715 Reduced 13.35%	76,030 $740,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $475,101 - $634,353	66,355 Added 310.22%	87,745 $724,000
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $48,095 - $108,440	5,645 Added 35.85%	21,390 $204,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $146,428 - $239,166	15,745 New	15,745 $146,000
Q3 2020 Nov 16, 2020	SELL	$8.24 - $30.8 $226,600 - $847,000	-27,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $205,150 - $644,050	27,500 New	27,500 $532,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.